List of Tables
Summary Table: Global Market for Autoimmune Disease Diagnostics, by Indication, Through 2026
Table 1: Association of Immune Dysfunction Syndromes Associated with Autoimmune Diseases
Table 2: Infectious Etiologies of Selected Autoimmune Diseases
Table 3: List of Autoimmune and Autoimmune Related Diseases
Table 4: Autoantibodies and Associated Diseases
Table 5: Challenges Faced by Immunoassay Kit/Instrument Manufacturers
Table 6: Challenges Faced by Immunoassay Clinical Laboratories
Table 7: Immunoassay Challenges Faced by Physicians
Table 8: Global Market for Autoimmune Disease Diagnostics, by Gender, Through 2026
Table 9: Global Market for Autoimmune Disease Diagnostics in Female, by Region, Through 2026
Table 10: Global Market for Autoimmune Disease Diagnostics in Male, by Region, Through 2026
Table 11: Global Market for Autoimmune Disease Diagnostics, by Technology, Through 2026
Table 12: ANA Patterns and Associated Diseases
Table 13: Conditions Associated with Positive IIF-ANA Results
Table 14: Global Market for Indirect Immunofluorescence (IIF) of Autoimmune Disease Diagnostics, by Region, Through 2026
Table 15: Global Market for Enzyme-linked Immunosorbent Assay (ELISA) of Autoimmune Disease Diagnostics, by Region, Through 2026
Table 16: Global Market for ImmunoBlot of Autoimmune Disease Diagnostics, by Region, Through 2026
Table 17: Global Market for Multiplex Immunoassays of Autoimmune Disease Diagnostics, by Region, Through 2026
Table 18: Global Market for Other Technologies Segment of Autoimmune Disease Diagnostics, by Region, Through 2026
Table 19: Prevalence of ANA in Various Connective Tissue Diseases (CTD)
Table 20: Performance of Laboratory Methods in Detection of Autoimmune Antibodies
Table 21: Autoimmune Products Sold, by Selected Multinational Companies, by Technology
Table 22: Global Market for Autoimmune Disease Diagnostics, by Indication, Through 2026
Table 23: Global Market for Autoimmune Disease Diagnostics for Type 1 Diabetes, by Region, Through 2026
Table 24: Global Market for Autoimmune Disease Diagnostics for Rheumatoid Arthritis, by Region, Through 2026
Table 25: Global Market for Autoimmune Disease Diagnostics for Psoriasis/Psoriatic Arthritis, by Region, Through 2026
Table 26: Drugs in the Pipeline for Psoriatic Disease
Table 27: Global Market for Autoimmune Disease Diagnostics for Multiple Sclerosis, by Region, Through 2026
Table 28: Global Market for Autoimmune Disease Diagnostics for Inflammatory Bowel Disease, by Region, Through 2026
Table 29: Global Market for Autoimmune Disease Diagnostics for Systemic Lupus Erythematosus, by Region, Through 2026
Table 30: Global Market for Autoimmune Disease Diagnostics for Other Diseases Indication, by Region, Through 2026
Table 31: Global Market for Autoimmune Disease Diagnostics, by Region, Through 2026
Table 32: North American Market for Autoimmune Disease Diagnostics, by Gender, Through 2026
Table 33: North American Market for Autoimmune Disease Diagnostics, by Technology, Through 2026
Table 34: North American Market for Autoimmune Disease Diagnostics, by Indication, Through 2026
Table 35: North American Market for Autoimmune Disease Diagnostics, by Country, Through 2026
Table 36: European Market for Autoimmune Disease Diagnostics, by Gender, Through 2026
Table 37: European Market for Autoimmune Disease Diagnostics, by Technology, Through 2026
Table 38: European Market for Autoimmune Disease Diagnostics, by Indication, Through 2026
Table 39: European Market for Autoimmune Disease Diagnostics, by Country, Through 2026
Table 40: Asia-Pacific Market for Autoimmune Disease Diagnostics, by Gender, Through 2026
Table 41: Asia-Pacific Market for Autoimmune Disease Diagnostics, by Technology, Through 2026
Table 42: Asia-Pacific Market for Autoimmune Disease Diagnostics, by Indication, Through 2026
Table 43: Asia-Pacific Market for Autoimmune Disease Diagnostics, by Country, Through 2026
Table 44: Rest of World Market for Autoimmune Disease Diagnostics, by Gender, Through 2026
Table 45: Rest of World Market for Autoimmune Disease Diagnostics, by Technology, Through 2026
Table 46: Rest of World Market for Autoimmune Disease Diagnostics, by Indication, Through 2026
Table 47: Rest of World Market for Autoimmune Disease Diagnostics, by Country, Through 2026
Table 48: Pharmaceutical Companies Involved in COVID-19 Testing and Research
Table 49: Companies Offering FDA Emergency Use Authorization Serology Tests with Locations in the United States
Table 50: Per Capita Health Expenditure in Select Countries, 2016-2018
Table 51: Out-of-Pocket Health Expenditures, by Major Countries, 2016-2018
Table 52: Diagnostic Chains Well-positioned to Improve their Operating Parameters Within India
Table 53: Major Manufacturers of Autoimmune Disease Diagnostics, by Revenue* and Number of Employees, 2020
Table 54: Differences between U.S. and European Government Regulations for Medical Devices
Table 55: Regulation of Medical Diagnostics in Selected Asia-Pacific Countries
Table 56: Major Mergers and Acquisitions in the Global Autoimmune Disease Diagnostics Market, 2021
Table 57: Agreements, Launches, Collaborations and Partnerships in the Global Autoimmune Disease Diagnostics Market, 2021
Table 58: Abbott: Product Portfolio
Table 59: BD Biosciences: Product Portfolio
Table 60: Beckman Coulter Inc (Danaher).: Product Portfolio
Table 61: bioMérieux: Product Portfolio
Table 62: Bio-Rad: Product Portfolio
Table 63: Bristol-Myers Squibb: Product Portfolio
Table 64: Euroimmun (PerkinElmer): Product Portfolio
Table 65: F. Hoffmann-La Roche AG: Product Portfolio
Table 66: Siemens Healthcare: Product Portfolio
Table 67: Thermo Fisher Scientific: Product Portfolio
Table 68: Trinity Biotech: Product Portfolio
Table 69: Acronyms Used in This Report
List of Figures
Summary Figure: Global Market Shares of Autoimmune Disease Diagnostics, by Indication, 2020
Figure 1: Prevalence of Selected Autoimmune Diseases in the U.S., 2020
Figure 2: Prevalence of Diagnosed Autoimmune Conditions in Selected Countries, 2019
Figure 3: Deaths Due to Diabetes in Adults, by Age Group and Sex, 2019
Figure 4: Number of Diabetes Patients (Ages 20-79 years), Projection and Trends, 2000-2045
Figure 5: Technological Development for Some Autoimmune Diseases
Figure 6: Global Market Shares of Autoimmune Disease Diagnostics, by Gender, 2020
Figure 7: Global Market for Autoimmune Disease Diagnostics in Female, 2019-2026
Figure 8: Global Market for Autoimmune Disease Diagnostics in Female, by Region, 2019-2026
Figure 9: Global Market for Autoimmune Disease Diagnostics in Male, 2019-2026
Figure 10: Global Market for Autoimmune Disease Diagnostics in Male, by Region, 2019-2026
Figure 11: Global Market Shares of Autoimmune Disease Diagnostics, by Technology, 2020
Figure 12: IIF-ANA Test Methodology
Figure 13: Global Market for Indirect Immunofluorescence (IIF) of Autoimmune Disease Diagnostics, 2019-2026
Figure 14: Global Market for IIF of Autoimmune Disease Diagnostics, by Region, 2019-2026
Figure 15: ELISA Testing Methodology
Figure 16: Global Market for Enzyme-linked Immunosorbent Assay (ELISA) of Autoimmune Disease Diagnostics, 2019-2026
Figure 17: Global Market for ELISA of Autoimmune Disease Diagnostics, by Region, 2019-2026
Figure 18: Western Blot Methodology
Figure 19: Dot Blot Test Assay Methodology
Figure 20: ANA Line Assay Methodology
Figure 21: Global Market for ImmunoBlot Test Assay of Autoimmune Disease Diagnostics, 2019-2026
Figure 22: Global Market for ImmunoBlot of Autoimmune Disease Diagnostics, by Region, 2019-2026
Figure 23: ANA Flow Cytometry Assay Methodology
Figure 24: Global Market for Multiplex Immunoassays of Autoimmune Disease Diagnostics, 2019-2026
Figure 25: Global Market for Multiplex Immunoassays of Autoimmune Disease Diagnostics, by Region, 2019-2026
Figure 26: ANA Agglutination Assay Methodology
Figure 27: ANA Double Immune Diffusion Assay Methodology
Figure 28: Counterimmunoelectrophoresis Methodology
Figure 29: Global Market for Other Technologies Segment of Autoimmune Disease Diagnostics, 2019-2026
Figure 30: Global Market for Other Technologies Segment of Autoimmune Disease Diagnostics, by Region, 2019-2026
Figure 31: Global Market Shares of Autoimmune Disease Diagnostics, by Indication, 2020
Figure 32: Global Prevalence of Major Autoimmune Diseases, 2016 and 2017
Figure 33: Global Market for Autoimmune Disease Diagnostics for Type 1 Diabetes, 2019-2026
Figure 34: Global Market for Autoimmune Disease Diagnostics for Type 1 Diabetes, by Region, 2019-2026
Figure 35: Global Market for Autoimmune Disease Diagnostics for Rheumatoid Arthritis, 2019-2026
Figure 36: Global Market for Autoimmune Disease Diagnostics for Rheumatoid Arthritis, by Region, 2019-2026
Figure 37: Global Market for Autoimmune Disease Diagnostics for Psoriasis/Psoriatic Arthritis, 2019-2026
Figure 38: Global Market for Autoimmune Disease Diagnostics for Psoriasis/Psoriatic Arthritis, by Region, 2019-2026
Figure 39: Global Market for Autoimmune Disease Diagnostics for Multiple Sclerosis, 2019-2026
Figure 40: Global Market for Autoimmune Disease Diagnostics for Multiple Sclerosis, by Region, 2019-2026
Figure 41: Global Market for Autoimmune Disease Diagnostics for Inflammatory Bowel Disease, 2019-2026
Figure 42: Global Market for Autoimmune Disease Diagnostics for Inflammatory Bowel Disease, by Region, 2019-2026
Figure 43: Global Market for Autoimmune Disease Diagnostics for Systemic Lupus Erythematosus, 2019-2026
Figure 44: Global Market for Autoimmune Disease Diagnostics for Systemic Lupus Erythematosus, by Region, 2019-2026
Figure 45: Global Market for Autoimmune Disease Diagnostics for Other Diseases Indication, 2019-2026
Figure 46: Global Market for Autoimmune Disease Diagnostics for Other Diseases Indication, by Region, 2019-2026
Figure 47: Global Market Shares of Autoimmune Disease Diagnostics, by Region, 2020
Figure 48: North American Market Shares of Autoimmune Disease Diagnostics, by Gender, 2020
Figure 49: North American Market Shares of Autoimmune Disease Diagnostics, by Technology, 2020
Figure 50: North American Market Shares of Autoimmune Disease Diagnostics, by Indication, 2020
Figure 51: North American Market Shares of Autoimmune Disease Diagnostics, by Country, 2020
Figure 52: U.S. Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 53: Canadian Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 54: Mexican Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 55: European Market Shares of Autoimmune Disease Diagnostics, by Gender, 2020
Figure 56: European Market Shares of Autoimmune Disease Diagnostics, by Technology, 2020
Figure 57: European Market Shares of Autoimmune Disease Diagnostics, by Indication, 2020
Figure 58: European Market Shares of Autoimmune Disease Diagnostics, by Country, 2020
Figure 59: German Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 60: French Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 61: U.K. Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 62: Italian Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 63: Spanish Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 64: Rest of the European Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 65: Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Gender, 2020
Figure 66: Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Technology, 2020
Figure 67: Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Indication, 2020
Figure 68: Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Country, 2020
Figure 69: Japanese Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 70: Chinese Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 71: Share of Autoimmune Disease Diagnostic Costs* in China, by Type of Therapy, 2020
Figure 72: Indian Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 73: Australian and New Zealand Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 74: Healthcare Expenditure in Australia, 2015 and 2016
Figure 75: Rest of Asia-Pacific Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 76: Rest of World Market Shares of Autoimmune Disease Diagnostics, by Gender, 2020
Figure 77: Rest of World Market Shares of Autoimmune Disease Diagnostics, by Technology, 2020
Figure 78: Rest of World Market Shares of Autoimmune Disease Diagnostics, by Indication, 2020
Figure 79: Rest of World Market Shares of Autoimmune Disease Diagnostics, by Country, 2020
Figure 80: Brazilian Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 81: GCC Countries Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 82: South African Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 83: Other RoW Countries Market for Autoimmune Disease Diagnostics, 2019-2026
Figure 84: Ups and Down of Diagnostic Field during COVID-19
Figure 85: Autoimmune Disease Diagnostics Industry Value Chain
Figure 86: Per Capita Health Expenditure in Select Countries, 2016-2018
Figure 87: Molecular Tests Approved in the United States, by Therapy Area, 2016
Figure 88: Global Market Shares of Autoimmune Disease Diagnostics, by Manufacturer, 2020
Figure 89: SWOT Analysis of the Global Autoimmune Disease Diagnostics Market
Figure 90: Abbott: Annual Revenue, 2016-2020
Figure 91: Abbott: Revenue Share, by Country, 2020
Figure 92: Abbott: Revenue Share, by Business Unit, 2020
Figure 93: BD Biosciences: Annual Revenue, 2017-2020
Figure 94: BD Biosciences: Revenue Share, by Business Segment, 2020
Figure 95: BD Biosciences: Revenue Share, by Medical Segment, 2020
Figure 96: Beckman Coulter Inc (Danaher): Annual Revenue, 2018-2020
Figure 97: Beckman Coulter Inc (Danaher): Revenue Share, by Region in Diagnostic Segment, 2020
Figure 98: Beckman Coulter Inc (Danaher): Revenue Share, by Business Segment, 2020
Figure 99: bioMérieux: Annual Revenue, 2018-2020
Figure 100: bioMérieux: Revenue Share, by Region/Country, 2020
Figure 101: bioMérieux: Revenue Share, by Business Unit, 2019
Figure 102: Bio-Rad: Annual Revenue, 2017-2020
Figure 103: Bio-Rad: Revenue Share, by Region, 2020
Figure 104: Bio-Rad: Revenue Share, by Business Unit, 2020
Figure 105: Bristol-Myers Squibb: Annual Revenue, 2016-2020
Figure 106: Bristol-Myers Squibb: Revenue Share, by Region, 2020
Figure 107: Bristol-Myers Squibb: R&D Market Share, 2019 and 2020
Figure 108: Euroimmun (PerkinElmer): Annual Revenue, 2017-2020
Figure 109: Euroimmun (PerkinElmer): Revenue Share, by Region, 2020
Figure 110: Euroimmun (PerkinElmer): Revenue Share, by Business Unit, 2019
Figure 111: F. Hoffmann-La Roche AG: Annual Revenue, 2016-2020
Figure 112: F. Hoffmann-La Roche AG: Revenue Share in Diagnostic Segment, by Region, 2020
Figure 113: F. Hoffmann-La Roche AG: Revenue Share, by Diagnostic Segment, 2019
Figure 114: Siemens Healthcare: Annual Revenue, 2019 and 2020
Figure 115: Siemens Healthcare: Revenue Share, by Region, 2020
Figure 116: Siemens Healthcare: Revenue Share, by Business Unit, 2020
Figure 117: Thermo Fisher Scientific: Annual Revenue, 2016-2020
Figure 118: Thermo Fisher Scientific: Revenue Share, by Region, 2020
Figure 119: Thermo Fisher Scientific: Revenue Share, by Business Segment, 2020
Figure 120: Trinity Biotech: Annual Revenue, 2019 and 2020
Figure 121: Trinity Biotech: Revenue Share, by Region, 2020
Figure 122: Trinity Biotech: Revenue Share, by Business Segment, 2020
